Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Arerugi = [Allergy]|March 1, 1992
[The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia]S Tada, J Namba, S Yokota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1987
[A phase I study of carboplatin]M Ogawa, K Imajo, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1986
[Brain metastasis from breast cancer]K Miyaoka, M Ogawa, N Horikoshi, et al.
Annals of Hematology|June 28, 2000
Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemiaJ Tsuchiyama, K Imajo, N Sakaguchi, et al.
Annals of Hematology|April 27, 2002
Lymphomatous polyp of mantle cell type in the duodenum complicated by gastric cancer: a case of trisomy 3 and t(11;14)(q13;q32)J Tsuchiyama, T Yoshino, K Imajo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 24, 1999
[A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group]T Chou, T Ishiguro, K Imajo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 24, 1999
[An early phase II study of autologous peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission. Japan Blood Cell Transplantation Study Group]F Kawano, T Kiyokawa, K Shinagawa, et al.
Annals of Hematology|November 9, 2002
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three casesJ Tsuchiyama, K Imajo, T Yoshino, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2018
Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiativeW-K Chan, S Treeprasertsuk, K Imajo, et al.
Pageof 2